Levels of Interleukin 27 and Interleukin 35 in the Serum and Vitreous of Patients with Proliferative Diabetic Retinopathy

REFERENCES

• Nolan CJ, Damm P, M. Prentki Type 2 diabetes across generations: from pathophysiology to prevention and management. Lancet. 2011;378(9786):169 – 181.
   PubMed Web of Science ®Google Scholar
• Jasinski JP, Butcher RJ, Hakim Al-Arique QN, et al. Desipramine hydrochloride: a non-merohedrally twinned structure. Acta Crystallogr Sect E Struct Rep Online. 2010;66(Pt 3):674 – 675.
   Google Scholar
• Saaddine JB, Honeycutt AA, Narayan KM, et al. Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050. Arch Ophthalmol. 2008;126(12):1740 – 1747.
   PubMedGoogle Scholar
• Giacco F, Brownlee M. Oxidative stress and diabetic complications. Circ Res. 2010;107(9):1058 – 1070.
   PubMed Web of Science ®Google Scholar
• Milne R, Brownstein S. Advanced glycation end products and diabetic retinopathy. Amino Acids. 2013;44(6):1397 – 1407.
   PubMed Web of Science ®Google Scholar
• Feenstra DJ, Yego EC, Mohr S. Modes of retinal cell death in diabetic retinopathy. J Clin Exp Ophthalmol. 2013;4(5):298.
   PubMedGoogle Scholar
• Tomic M, Ljubic S, Kastelan S. The role of inflammation and endothelial dysfunction in the pathogenesis of diabetic retinopathy. Coll Antropol. 2013;37 Suppl 1:51 – 57.
   PubMedGoogle Scholar
• Wu C, Goodall JC, Busch R, et al. Relationship of CD146 expression to secretion of interleukin (IL)-17, IL-22 and interferon-gamma by CD4(+) T cells in patients with inflammatory arthritis. Clin Exp Immunol. 2015;179(3):378 – 391.
   PubMed Web of Science ®Google Scholar
• Fonseca-Camarillo G, Yamamoto-Furusho JK. Immunoregulatory pathways involved in inflammatory bowel disease. Inflamm Bowel Dis. 2015;21(9):2188 – 2193.
   PubMed Web of Science ®Google Scholar
• Weber MS, Hemmer B. Cooperation of B cells and T cells in the pathogenesis of multiple sclerosis. Results Probl Cell Differ. 2010;51:115 – 126.
   PubMedGoogle Scholar
• Xia H, Ye ZJ, Zhou Q, et al. IL-27 and IL-27-producing CD4+ T cells in human tuberculous pleural effusion. Tuberculosis (Edinb). 2014;94(6):579 – 588.
   PubMed Web of Science ®Google Scholar
• Wang C, Tian Y, Lei B, et al. Decreased IL-27 expression in association with an increased Th17 response in Vogt-Koyanagi-Harada disease. Invest Ophthalmol Vis Sci. 2012;53(8):4668 – 675.
   PubMed Web of Science ®Google Scholar
• Winkler G, Dworak O, Salamon F, et al. Increased interleukin-12 plasma concentrations in both, insulin-dependent and non-insulin-dependent diabetes mellitus. Diabetologia. 1998;41(4):488.
   PubMed Web of Science ®Google Scholar
• Gverović Antunica A, Karaman K, Znaor L, et al. IL-12 concentrations in the aqueous humor and serum of diabetic retinopathy patients. Graefes Arch Clin Exp Ophthalmol. 2012;250(6):815 – 821.
   PubMed Web of Science ®Google Scholar
• Dong N, Xu B, Chu L, et al. Study of 27 aqueous humor cytokines in type 2 diabetic patients with or without macular edema. PLoS One. 2015;10(4):e0125329.
   PubMed Web of Science ®Google Scholar
• Xu H, Cai M, Zhang X. Effect of the blockade of the IL-23-Th17-IL-17A pathway on streptozotocin-induced diabetic retinopathy in rats. Graefes Arch Clin Exp Ophthalmol. 2015;253(9):1485 – 1492.
   PubMed Web of Science ®Google Scholar
• Roohi A, Tabrizi M, Abbasi F, et al. Serum IL-17, IL-23, and TGF-beta levels in type 1 and type 2 diabetic patients and age-matched healthy controls. Biomed Res Int. 2014;2014:718946.
   PubMedGoogle Scholar
• Takeuchi M, Sato T, Tanaka A, et al. Elevated levels of cytokines associated with Th2 and Th17 cells in vitreous fluid of proliferative diabetic retinopathy patients. PLoS One. 2015;10(9):e0137358.
   PubMed Web of Science ®Google Scholar
• Yoshida H, Y. Miyazaki Interleukin 27 signaling pathways in regulation of immune and autoimmune responses. Int J Biochem Cell Biol. 2008;40(11):2379 – 2383.
   PubMed Web of Science ®Google Scholar
• Murugaiyan G, Mittal A, Lopez-Diego R, et al. IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells. J Immunol. 2009;183(4):2435 – 2443.
   PubMed Web of Science ®Google Scholar
• Hall AO, Silver JS, Hunter CA. The immunobiology of IL-27. Adv Immunol. 2012;115:1 – 44.
   PubMed Web of Science ®Google Scholar
• Vignali DA, Kuchroo VK. IL-12 family cytokines: immunological playmakers. Nat Immunol. 2012;13(8):722 – 728.
   PubMed Web of Science ®Google Scholar
• Bettini M, Castellaw AH, Lennon GP, et al. Prevention of autoimmune diabetes by ectopic pancreatic beta-cell expression of interleukin-35. Diabetes. 2012;61(6):1519 – 1526.
   PubMed Web of Science ®Google Scholar
• Fujimoto H, Hirase T, Miyazaki Y, et al. IL-27 inhibits hyperglycemia and pancreatic islet inflammation induced by streptozotocin in mice. Am J Pathol. 2011;179(5):2327 – 2336.
   PubMed Web of Science ®Google Scholar
• Singh K, Kadesjö E, Lindroos J, et al. Interleukin-35 administration counteracts established murine type 1 diabetes–possible involvement of regulatory T cells. Sci Rep. 2015;5:126 – 133.
   Web of Science ®Google Scholar
• Wilkinson CP, Ferris FL 3rd, Klein RE, et al. Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology. 2003;110(9):1677 – 1682.
   PubMed Web of Science ®Google Scholar
• Fujita T, Hemmi S, Kajiwara M, et al. Complement-mediated chronic inflammation is associated with diabetic microvascular complication. Diabetes Metab Res Rev. 2013;29(3):220 – 226.
   PubMed Web of Science ®Google Scholar
• Adamis AP, Berman AJ. Immunological mechanisms in the pathogenesis of diabetic retinopathy. Semin Immunopathol. 2008;30(2):65 – 84.
   PubMed Web of Science ®Google Scholar
• Kern TS. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res. 2007;2007:95 – 103.
   Google Scholar
• Itoi K, Nakamura K, Oku H, et al. Relationship between diabetic macular edema and peripheral Th1/Th2 balance. Ophthalmologica. 2008;222(4):249 – 253.
   PubMed Web of Science ®Google Scholar
• Wu CC, Sytwu HK, Lu KC, et al. Role of T-cells in type 2 diabetic nephropathy. Exp Diabetes Res. 2011;2011:514 – 738.
   Google Scholar
• Zeng C, Shi X, Zhang B, et al. The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications. J Mol Med (Berl). 2012;90(2):175 – 186.
   PubMed Web of Science ®Google Scholar
• Jones GW, Bombardieri M, Greenhill CJ, et al. Interleukin-27 inhibits ectopic lymphoid-like structure development in early inflammatory arthritis. J Exp Med. 2015;212(11):1793 – 1802.
   PubMed Web of Science ®Google Scholar
• Watzlawick R, Kenngott EE, Liu FD, et al. Anti-inflammatory effects of IL-27 in zymosan-induced peritonitis: inhibition of neutrophil recruitment partially explained by impaired mobilization from bone marrow and reduced chemokine levels. PLoS One. 2015;10(9):e0137651.
   PubMed Web of Science ®Google Scholar
• Babaloo Z, Yeganeh RK, Farhoodi M, et al. Increased IL-17A but decreased IL-27 serum levels in patients with multiple sclerosis. Iran J Immunol. 2013;10(1):47 – 54.
   PubMed Web of Science ®Google Scholar
• Li TT, Zhang T, Chen GM, et al. Low level of serum interleukin 27 in patients with systemic lupus erythematosus. J Investig Med. 2010;58(5):737 – 739.
   PubMed Web of Science ®Google Scholar
• Duan M, Ning Z, Fu Z, et al. Decreased IL-27 negatively correlated with Th17 cells in non-small-cell lung cancer patients. Mediators Inflamm. 2015;2015:802 – 939.
   Google Scholar
• Jafarzadeh A, Nemati M, Rezayati MT. Serum levels of interleukin (IL)-27 in patients with ischemic heart disease. Cytokine. 2011;56(2):153 – 156.
   PubMed Web of Science ®Google Scholar
• Wang R, Han G, Wang J, et al. The pathogenic role of interleukin-27 in autoimmune diabetes. Cell Mol Life Sci. 2008;65(23):3851 – 3860.
   PubMed Web of Science ®Google Scholar
• Li X, Mai J, Virtue A, et al. IL-35 is a novel responsive anti-inflammatory cytokine–a new system of categorizing anti-inflammatory cytokines. PLoS One. 2012;7(3):e33628.
   PubMed Web of Science ®Google Scholar
• Ning X, Jian Z, Wang W. Low serum levels of interleukin 35 in patients with rheumatoid arthritis. Tohoku J Exp Med. 2015;237(2):77 – 82.
   PubMed Web of Science ®Google Scholar
• Ouyang H, Shi YB, Liu ZC, et al. Decreased interleukin 35 and CD4+EBI3+ T cells in patients with active systemic lupus erythematosus. Am J Med Sci. 2014;348(2):156 – 161.
   PubMed Web of Science ®Google Scholar
• Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11(2):98 – 107.
   PubMed Web of Science ®Google Scholar
• Lee MS. Role of innate immunity in the pathogenesis of type 1 and type 2 diabetes. J Korean Med Sci. 2014;29(8):1038 – 1041.
   PubMed Web of Science ®Google Scholar
• Meka RR, Venkatesha SH, Dudics S, et al. IL-27-induced modulation of autoimmunity and its therapeutic potential. Autoimmun Rev. 2015;14(12):1131 – 1141.
   PubMed Web of Science ®Google Scholar
• Xia LP, Li BF, Shen H, et al. Interleukin-27 and interleukin-23 in patients with systemic lupus erythematosus: possible role in lupus nephritis. Scand J Rheumatol. 2015;44(3):200 – 205.
   PubMed Web of Science ®Google Scholar